Top 10 BPH articles and videos of 2024

There has been a lot of news about benign prostatic hyperplasia (BPH) over the past year. To celebrate these breakthroughs, the editorial staff at Urology Times® are showcasing our best content on BPH from 2024.

Olivia Paulsen on the association between BPH and erectile dysfunction

In this video, Olivia Paulsen gives an overview of the study “Benign Prostatic Enlargement Is Associated With Erectile Dysfunction in United States,” which she presented at the 25th Fall Scientific Meeting of the Sexual Medicine Society of North in Scottsdale, Arizona. Watch the video here

Investigators compare costs for surgical treatments of BPH

In this video, Kevin M. Wymer, MD, shares the background and notable findings from the recent Urology paper “Evaluation of Private Payer and Patient Out of Pocket Costs Associated with the Surgical Management of Benign Prostatic Hyperplasia.” Watch the video here

Erectile and ejaculatory function preserved with Optilume BPH Catheter System

Treatment of lower urinary tract symptoms (LUTS) secondary to BPH with the Optilume BPH Catheter System appears to preserve erectile and ejaculatory function in addition to providing relief from LUTS, according to a study presented at the 2024 American Urological Association Annual Meeting in San Antonio, Texas. Read more here

Urologist discusses Aquablation, rise in large prostates seen in his practice

In this video, Joseph Song, MD, discusses Aquablation and shares an observation regarding an increase in large prostates. Watch the video here

Aquablation granted new category I CPT code for BPH management

The American Medical Association has granted a Category I Current Procedural Terminology (CPT) code to Aquablation for the management of BPH, thus replacing the therapy’s existing Category III CPT code. Learn more here

FDA grants 510(k) clearance to AI-powered robotic system for Aquablation therapy

The FDA has granted 510(k) clearance to the HYDROS robotic system, an AI-powered platform designed to enhance the delivery of Aquablation therapy for patients with BPH, PROCEPT BioRobotics, the developer of the platform, announced in a news release. Read more here

Phase 1/2 trial launches of Focal One robotic HIFU for BPH

The first patients have been treated in a phase 1/2 study (NCT06601179) evaluating the safety and efficacy of Focal One robotic high-intensity focused ultrasound in the treatment of patients with BPH, EDAP TMS SA announced in a news release. Learn more here

Study of ProVee System for BPH hits enrollment goal

The target enrollment has been met in the ProVIDE trial (NCT05186740), which is evaluating the safety and efficacy of the ProVee System, a stent-like urethral expander for the treatment of patients with lower urinary tract symptoms secondary to BPH, announced ProVerum, the developer of the therapy, in a news release. Read more here

Dr. Sterling and Dr. Friel describe initial experience, patient selection for Aquablation for BPH

In this interview, Matthew E. Sterling, MD, and Brian Friel, MD, discuss the Aquablation procedure for the treatment of BPH, including how the procedure works, what patient selection is like, and what advice they would give other providers just starting out with Aquablation. Learn more here

Real-world data support safety, efficacy of Aquablation for BPH-related LUTS

Data from a post-market survey presented at the Japanese Urological Association Annual Meeting support the safety and efficacy of Aquablation therapy in men in Japan with lower urinary tract symptoms due to BPH. Read more here